HomeALLO • NASDAQ
add
Allogene Therapeutics Inc
Previous close
$1.12
Day range
$1.11 - $1.23
Year range
$0.86 - $3.78
Market cap
264.04M USD
Avg Volume
4.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 14.28M | -11.23% |
Net income | -50.94M | 23.23% |
Net profit margin | — | — |
Earnings per share | -0.22 | 31.31% |
EBITDA | -51.33M | 18.26% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 273.12M | -38.57% |
Total assets | 470.59M | -27.25% |
Total liabilities | 126.03M | -4.41% |
Total equity | 344.56M | — |
Shares outstanding | 221.88M | — |
Price to book | 0.71 | — |
Return on assets | -27.81% | — |
Return on capital | -30.05% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -50.94M | 23.23% |
Cash from operations | -39.03M | 38.62% |
Cash from investing | 43.84M | -41.25% |
Cash from financing | 5.07M | -95.33% |
Net change in cash | 9.88M | -91.74% |
Free cash flow | -18.92M | 6.33% |
About
Founded
2017
Headquarters
Website
Employees
226
